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Many bacteria regulate the expression of virulence factors via carbon catabolite
responsive elements. In Gram-positive bacteria, the predominant mediator of carbon
catabolite repression is the catabolite control protein A (CcpA). Hyperglycemia is a
widespread disorder that predisposes individuals to an array of symptoms and an
increased risk of infections. In hyperglycemic individuals, the bacterium Staphylococcus
aureus causes serious, life-threatening infections. The importance of CcpA in regulating
carbon catabolite repression in S. aureus suggests it may be important for infections
in hyperglycemic individuals. To test this suggestion, hyperglycemic non-obese diabetic
(NOD; blood glucose level ≥20 mM) mice were challenged with the mouse pathogenic
S. aureus strain Newman and the isogenic ccpA deletion mutant (MST14), and the
effects on infectivity were determined. Diabetic NOD mice challenged with the ccpA
deletion mutant enhanced the symptoms of infection in an acute murine pneumonia
model relative to the parental strain. Interestingly, when diabetic NOD mice were used in
footpad or catheter infection models, infectivity of the ccpA mutant decreased relative to
the parental strain. These differences greatly diminished when normoglycemic NOD mice
(blood glucose level ≤10 mM) were used. These data suggest that CcpA is important for
infectivity of S. aureus in hyperglycemic individuals.
Keywords: Staphylococcus aureus, CcpA, infectivity, hyperglycemia, carbon catabolic regulation

INTRODUCTION
Diabetes mellitus is a common endocrinopathy in both household animals and humans (Bennett,
2002; Shaw et al., 2010). A common complication in diabetes is foot ulceration, which is typically
associated with limb bone and tissue infection, and incurring significant morbidity, disability,
and frequent lower limb amputation (reviewed in Game, 2010; Ambrosch et al., 2011). The
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MATERIAL AND METHODS

Gram-positive opportunistic pathogen Staphylococcus aureus
is one of the leading causes of this disease, either as a
singular microbial causative agent, and/or in synergy with other
pathogenic microorganisms (Yates et al., 2009). The availability
of an excellent diabetic mouse model that recapitulates the
human disease has greatly facilitated research into this growing
problem and should facilitate new therapeutic treatments.
S. aureus infections in diabetic mice are associated with increased
inflammation, endothelial injury, and blood coagulation (Rich
and Lee, 2005; Tsao et al., 2006; Hanses et al., 2011). In
addition, the killing of S. aureus in the diabetic host is
impaired due to a diminished leukocytic respiratory burst (Rich
and Lee, 2005). While these studies focused on host factors
involved in the immune response, little is known about the
bacterial factors that mediate S. aureus success in colonizing
and causing infections in diabetic foot ulcerations (DFU). That
being said, polysaccharide intercellular adhesion (PIA) synthesis
is common in S. aureus isolates obtained from patients with
DFU (Podbielska et al., 2010), and most S. aureus strains isolated
from DFU are positive for the epidermal cell differentiation
inhibitor EDIN (Messad et al., 2013). However, the importance
of PIA and EDIN in the infectivity of S. aureus in DFU is
unknown, and it remains to be seen whether PIA and EDIN are
expressed in the diabetic environment relative to normoglycemic
conditions.
PIA synthesis is encoded within the ica operon, and is
regulated in part by the catabolite control protein A (CcpA),
a glucose-responsive member of the LacI/GalR family of
transcriptional regulators (Seidl et al., 2008b). CcpA also
modulates transcription of exotoxins, such as α-hemolysin
and toxic shock syndrome toxin 1, protein A (SpA), and
capsule formation in a glucose-responsive manner (Seidl et al.,
2006, 2008a, 2009). More recently, CcpA was reported to
mediate proline and arginine auxotrophies under in vitro growth
conditions (Li et al., 2010; Nuxoll et al., 2012), and to contribute
to infectivity of S. aureus in a murine model of staphylococcal
abscess formation (Li et al., 2010). CcpA regulatory activity
in S. aureus is induced by carbon sources such as glucose,
fructose, glycerol, sucrose, mannitol, maltose, and salicin (Li
et al., 2010; Nuxoll et al., 2012), with as little as 4 mM of
glucose being sufficient to fully activate CcpA in vitro (Seidl
et al., 2008a). Furthermore, S. aureus CcpA activity is affected
by the serine/threonine kinase Stk1, which inactivates CcpA
via the phosphorylation of threonines 18 and 33 located in
the DNA binding site (Leiba et al., 2012). The environmental
stimuli that activate Stk1 to phosphorylate CcpA have yet to be
identified.
The prevalence of S. aureus infections in hyperglycemic
individuals, the preponderance of PIA positive S. aureus
isolates from DFU patients, and the CcpA-mediated regulation
of PIA, suggest that CcpA is important for infectivity of
S. aureus in a diabetic host. To test this hypothesis, the
ability of S. aureus strain Newman and its isogenic ccpA
mutant to elaborate infections in three independent murine
models using normo- and hyperglycemic conditions were
examined.
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Bacterial Strains, Plasmids, and Culture
Conditions
Bacterial strains and plasmids used in this study are listed in
Table 1. Bacteria were routinely grown at 37◦ C and 150 rpm
in tryptic soy broth (TSB) purchased from Becton Dickinson
(Heidelberg, Germany) with a culture to flask volume ratio of
1:10. As required, the medium was supplemented with 50 µg
kanamycin per milliliter.

Animal Models
Eight week old female C57BL/6N and non-obese diabetic mice
(NOD/ShiLtJ) were purchased from Charles River Laboratories
(Sulzfeld, Germany) and kept under specific pathogen-free
conditions according to the regulations of German and Swiss
veterinary law, respectively. All animal studies were performed
with the approval of the animal welfare committees Landesamt
für Verbraucherschutz (Saarbrucken, Germany), Landesamt
für Natur Umwelt und Verbraucherschutz (Recklinghausen,
Germany), and cantonal veterinary office of Basel-Stadt
(Switzerland), respectively. Female NOD mice spontaneously
develop type 1 diabetes mellitus usually between 15 and 30 weeks
of age (Leiter, 2001). Animals of 12 weeks of age were tested
weekly for increased urinary glucose levels, and subsequently
analyzed for blood glucose levels. Mice with blood glucose ≥20
mM were included as diabetic animals in the study. For all animal
models, phosphate buffered saline (PBS)-washed bacterial cells
obtained from exponential growth phase cultures (i.e., after 2 h
of growth in TSB at 37◦ C and 150 rpm) were used as inocula.
The murine lung infection model was performed as described
(Hartmann et al., 2014). Eight weeks old C57BL/6N mice were
slightly anesthetized by intraperitoneal injection of 100 mg/kg
body weight of ketamine hydrochloride (Pfizer, Berlin, Germany)
and 10 mg/kg of xylazine hydrochloride (Bayer, Leverkusen,
Germany), and infected intranasally with 5 × 107 colony forming
units (CFU) of S. aureus. Twenty-four hours post infection (p.i.),
the animals were euthanized, the tracheae were cannulated and a
broncho-alveolar lavage (BAL) was performed (three times with
1 ml of PBS). The BAL fluid was centrifuged at 300 × g for 10
min at 4◦ C to obtain alveolar cells, which were suspended in 1
ml of PBS. Total cell numbers in BAL were determined using a
Neubauer hemocytometer. To identify the bacterial load of the
lungs 24 h p.i., whole lungs were homogenized in 1 ml of PBS,
and serial dilutions were plated on sheep blood agar (SBA). CFU
were counted after incubation overnight at 37◦ C.
The footpad swelling model was carried out as described
(Nippe et al., 2011). Age-matched mice were inoculated
subcutaneously with 1 × 107 CFU of S. aureus into the left
hind footpad, and footpad swelling was measured daily with
a micrometric caliper in reference to the uninfected footpad.
Eleven days p.i., mice were killed by CO2 asphyxiation, and
footpad tissues aseptically sampled, homogenized in PBS, and
serial dilutions were plated on SBA to determine bacterial loads.
For the catheter-related biofilm infection model, mice were
anesthetized with isoflurane (Baxter, Volketswil, Switzerland)
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TABLE 1 | Strains and plasmids used in this study.
Relevant genotype and phenotypea

Reference or source

Newman

Mouse pathogenic laboratory strain (ATCC 25904)

Duthie, 1952

MST14

Newman 1ccpA::tet(L); TcR

Seidl et al., 2006

pCN34_ccpA

pCN34 derivative harboring ccpA and its native promoter; ApR in E. coli/KmR in S. aureus

Leiba et al., 2012

pCN34_ccpA_Ala

pCN34 with a ccpA derivative carrying the CcpA_T18A/T33A mutations under the control of the ccpA promoter; ApR in
E. coli/KmR in S. aureus

Leiba et al., 2012

Strain
S. aureus

Plasmids

a ApR ,

ampicillin resistant; KmR , kanamycin resistant; TcR , tetracyclin resistant.

poured into sterile petri dishes (Greiner Bio-One, Frickenhausen,
Germany). If needed, RBA plates were supplemented with 250 µl
of a sterile 40% glucose solution (final conc. 0.5%). Single colonies
of S. aureus were streaked onto RBA plates and grown for 24 h at
37◦ C. After 24 h, images of the plates were obtained with a Leica
D-Lux 3 in automatic mode.

and sterile catheter segments were inserted subcutaneously as
described (Rupp et al., 1999). Catheters were infected with 20
µl pyrogen-free saline containing 1 × 104 CFU of S. aureus,
before the incisions were closed with wound clips. The diameter
of swelling/edema was measured daily using a caliper. Ten
days after infection, mice were euthanized by intraperitoneal
injections of thiopenthal (500 mg/kg; Ospedalia AG, Hünenberg,
Switzerland), and the catheters and surrounding tissues were
aseptically removed and separated as described (Sadykov et al.,
2011). Briefly, bacteria adherent to the catheters were detached
by vortexing in 0.9% saline supplemented with 0.15% EDTA,
followed by sonication for 2 min at 250 W. Tissue samples were
homogenized in 1 ml 0.9% saline. Serial dilutions were plated on
SBA to determine the bacterial loads in catheters and tissues.
The murine abscess model was performed as described by
Li et al. (2010) with minor modifications. Briefly, 8 weeks old
C57BL/6N mice were anesthetized by intraperitoneal injection
of 100 mg/kg body weight of ketamine hydrochloride (Pfizer)
and 10 mg/kg of xylazine hydrochloride (Bayer), and infected
with 1 × 107 CFU of S. aureus via retro-orbital injection.
Infected mice received once a day an intraperitoneal injection
of the non-steroidal anti-inflammatory agent caprofen (5 mg/kg;
Pfizer) as pain relief, and 4 days p.i., mice were euthanized
with pentobarbital (400 mg/kg; Merial GmbH, Hallbergmoos,
Germany). Livers were removed and homogenized in PBS, and
serial dilutions of the homogenates were plated on SBA to
determine the amount of viable bacteria in the tissue, or used in
ELISAs for cytokine determinations.

Statistical Analyses
The significance of changes between groups was assessed with
the Mann–Whitney U test, using the GraphPad software package
Prism 6.01. P < 0.05 were considered significant.

RESULTS
Infectivity of S. aureus in Normoglycemic
Mice Is Independent of CcpA in Three
Different Mouse Models
Mice challenged with a S. aureus ccpA mutant displayed a
reduced bacterial load in liver tissue in an abscess model (Li et al.,
2010), suggesting that CcpA increases infectivity of S. aureus.
To expand upon the in vivo function of CcpA in facilitating
S. aureus infections, the effect of CcpA on infectivity was
tested with an isogenic S. aureus strain pair Newman/MST14
(Newman 1ccpA; Seidl et al., 2006) in three murine infection
models: an acute pneumonia model (Hartmann et al., 2014), a
subcutaneous footpad swelling model (Nippe et al., 2011), and a
catheter-related infection model (Rupp et al., 1999). In contrast
to the murine abscess model (Li et al., 2010), the infectivity of
S. aureus wild-type strain Newman and the 1ccpA mutant were
equivalent in all three animal models when using normoglycemic
C57BL/6N mice (Figure 1). Specifically, the bacterial loads in
lung tissue and BAL were similar in the pneumonia model
(Figure 1A); the swelling of footpads displayed comparable
kinetics and maxima (Figure 1B); and the edema formation
rates and bacterial loads in the catheter lumen and surrounding
tissues were indistinguishable in the catheter infection model
(Figure 1C). Taken together, these data demonstrate that under
normoglycemic conditions infectivity of S. aureus is independent
of CcpA.

Cytokine Determinations
Concentrations of murine IL-1β, IL-6, KC (the murine functional
homolog to CXCL-1/IL-8), and TNFα in infected livers were
determined by commercially available sandwich-type ELISAs,
according to the manufacturer’s instructions (R&D Systems,
Wiesbaden-Nordenstadt, Germany).

Rabbit Erythrocyte Hemolysis Assay
Rabbit blood agar (RBA) plates were prepared as follows: Fresh
citrated rabbit blood (1 ml) was centrifuged at 5,000 × g for
5 min at room temperature, and sedimented cells were washed
three times with 1 ml of 0.9% saline. After the last washing step,
cells were suspended in 0.5 ml of 0.9% saline and 500 µl of the
erythrocyte suspension was added to 20 ml of sterile Luria Bertani
agar (Becton Dickinson) that was cooled to 50◦ C. Washed
erythrocytes and Luria Bertani agar were gently mixed and
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CcpA Increases the Bacterial Load in Liver
Tissue of S. aureus Challenged Mice
Strain Newman and the isogenic ccpA mutant caused equivalent
infections in three mouse models, which differs from that
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data confirm the previous observations and demonstrate that
decreased bacterial burden in liver of mice infected with ccpA
mutants was due to the absence of CcpA. In addition, the data
raise the question as to why CcpA is important in liver abscesses,
but dispensable in other organs or anatomical sites?

CcpA Alters the Cytokine Response in
Liver Tissue of S. aureus Challenged Mice
In systemic infections, S. aureus elicits a strong pro-inflammatory
response by triggering the production and release of interleukins
(IL)-1β (IL-1β), IL-6, IL-8, IL-18, and tumor necrosis factor alpha
(TNFα) in immune and non-immune cells (Cui et al., 2000;
Feezor et al., 2003; Hessle et al., 2005; Muller-Anstett et al.,
2010). In S. aureus ccpA mutant challenged mice, the decreased
bacterial loads in the liver raised the question of whether the
lack of CcpA might also affect the innate immune response of
the infected mice. To test this hypothesis, the concentrations
of IL-1β, IL-6, TNFα, and the chemokine keratinocyte chemoattractant (KC, syn. CXCL-1) were determined in mouse liver
homogenates 4 days post-infection (Figures 2B,C and Figure S1).
As expected, the concentrations of IL-1β (Figure 2B) and KC
(Figure 2C) in the liver homogenates of MST14 challenged mice
were significantly decreased relative to wild-type infected mice.
Similarly, the cytokines IL-6 and TNFα were decreased in MST14
challenged mice; however, these effects were not statistically
significant (Figure S1). Upon challenge of mice with the ccpA
complemented MST14 derivative (MST14 pCN34_ccpA), the
cytokine concentrations in liver tissue were restored to levels
similar to mice infected with the wild-type strain (Figure 2B).
Taken together, these data suggest that ccpA-positive S. aureus
provoke an increased pro-inflammatory response in infected liver
tissue.

FIGURE 1 | Effect of a ccpA deletion on infectivity of S. aureus in
normoglycemic C57BL/6N mice. Normoglycemic female C57BL/6N mice
were challenged with S. aureus strain Newman (black symbols) or strain
MST14 (open symbols) in three infection models. Each symbol represents an
individual animal, and horizontal bars indicate the median of all mice.
(A) Bacterial loads in lung homogenates and in broncho-alveolar lavages
(BALs) 24 h p.i. in a lung infection model (n = 8 per group). (B) Footpad
swelling of S. aureus-infected mice in reference to the uninfected footpads
(means ± SEM) and total bacterial loads in infected feet 11 days p.i. in a
footpad infection model (n = 8 per group). (C) Size of edema and bacterial
loads in tissue surrounding the catheters and in the catheters’ lumen at day 11
p.i. in a catheter-related infection model (n = 6 per group).

The Phosphoablative ccpA Variant
Ccpa_T18A/T33A Affects the
Pathophysiology of S. aureus in the Murine
Abscess Model
Recently, it was determined that the DNA binding activity of
CcpA in S. aureus is controlled by the serine/threonine kinase
Stk1 (Leiba et al., 2012). To test whether the Stk1-dependent
phosphorylation of CcpA would affect the infectivity of S. aureus,
C57BL/6N mice were challenged with a MST14 derivative transcomplemented with a ccpA allele having threonine to alanine
mutations at positions 18 and 33 (MST14 pCN34_ccpA_Ala) and
the bacterial load and cytokine profiles were determined. This
CcpA_T18A/T33A variant can no longer be phosphorylated by
Stk1, but retains the regulatory activity toward its target genes
(Leiba et al., 2012). Interestingly, while the bacterial loads in livers
of mice infected with strain MST14 complemented with the wildtype ccpA allele were similar to those of mice challenged with the
wild-type strain, the infection progress differed in mice infected
with MST14 pCN34_ccpA_Ala (Figure 2A). Specifically, mice
challenged with MST14 pCN34_ccpA_Ala significantly increased
the bacterial load in livers by a factor of ∼1.8-log relative to the
MST14 infected mice, but remained ∼1.2- and ∼0.7-log below
the levels of the wild-type and MST14 pCN34_ccpA strains,

reported by Li et al. (2010). To determine if this difference
was due to the animal model or to differences in the type of
ccpA mutation (i.e., deletion mutant vs. transposon mutant),
the infectivity of strains Newman and the 1ccpA mutant in the
murine abscess model was assessed (Li et al., 2010). Consistent
with the findings of Li et al. (2010), a significant decrease (about
3-log) in the bacterial loads in liver was observed in mice
challenged with the 1ccpA mutant strain MST14 as compared
to mice infected with the wild-type strain Newman (Figure 2A).
Mice challenged with a trans-complemented MST14 derivative
harboring plasmid pCN34_ccpA displayed bacterial loads in liver
comparable to wild-type infected animals (1.1 × 108 ± 9.7 ×
107 CFU/g vs. 3.2 × 107 ± 1.8 × 107 CFU/g; P = 0.238). These
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FIGURE 2 | Stk1 phosphorylation of CcpA alters S. aureus infectivity in a murine abscess model. C57BL/6N mice (n = 6 per group) were challenged
retro-orbitally with 1 × 107 CFU of S. aureus strains Newman (black symbols), MST14 (white symbols), MST14 harboring plasmid pCN34_ccpA (light gray symbols),
and MST14 harboring plasmid pCN34_ccpA_Ala (dark gray symbols), respectively, and mice were sacrificed 4 days p.i. (A) Bacterial loads determined by plating
serial dilutions of homogenized tissue samples on sheep blood agar plates. (B,C) Cytokine levels of IL-1β (B) and KC [CXCL-1; (C)] in homogenized liver tissue of
infected animals at 4 days p.i. are depicted. Data given in (B) and (C) represent the mean ± SD (n = 6). *P < 0.05; **P < 0.01 (Mann–Whitney U-test).

(∼2.7-log; Figure 3A) and BALs (∼2.5-log; Figure 3B). This was
accompanied by a significant increase in total immune cells in
BALs of the MST14 challenged mice (Figure 3C), indicating an
increased severity of infection. Complementation of the 1ccpA
mutant with plasmid pCN34_ccpA restored all virulence traits
to wild-type levels, confirming that the alterations observed with
MST14 were caused by inactivation of ccpA.
To determine if CcpA was important for extrapulmonary
S. aureus infections in diabetic NOD mice, strain Newman
and MST14 were evaluated in the footpad swelling model
and catheter related infection models. The pCN34_ccpA
harboring MST14 derivative was not included, as maintenance
of the pT181-derived plasmid within the trans-complemented
derivative was not assured over the entire time course of these
in vivo models (Krute et al., 2016). Similar to our findings
with the pneumonia model, the wild-type and 1ccpA mutant
infected normoglycemic mice displayed comparable footpad
swelling kinetics (Figure 4A), and both strains persisted in the
infected foot tissue for a comparable number of 11 days p.i.
(Figure 4B). In contrast, when hyperglycemic NOD mice were
infected with strains Newman and MST14, clear differences in
the footpad swelling kinetics were observed (Figure 4A). The
footpads of mice infected with the wild-type strain Newman
showed enhanced swelling rates 5 days p.i. that were significantly
increased at days 8 and 9 when compared to the footpad
swelling rates of the strain MST14 challenged mice. Consistent
with increased footpad swelling, significantly greater numbers of
bacteria (∼7.1-fold) were recovered from the tissue homogenates
of infected feet of mice challenged with wild-type S. aureus in
comparison to mice infected with the 1ccpA mutant (Figure 4B).
Similar to the footpad swelling model, infection symptoms
in mice infected with strain Newman and MST14 were
equivalent in normoglycemic NOD mice using a catheter
related infection model (Rupp et al., 1999; Figure 5). In
contrast, infection of diabetic NOD mice with the wild-type
strain Newman significantly increased edema (Figure 5A) and

respectively (Figure 2A). Similarly, infecting mice with strain
MST14 pCN34_ccpA_Ala resulted in a significant increase in the
IL-1β levels in liver relative to that observed in mice challenged
with the wild-type or MST14 pCN34_ccpA strains (Figure 2B).
In contrast, KC levels were indistinguishable between these three
groups (Figure 2C). Taken together, under in vivo conditions the
Stk1-dependent phosphorylation of CcpA dramatically alters the
infection process.

Ccpa Alters the Infectivity of S. aureus in a
Hyperglycemic Environment
As mentioned, mice challenged with a ccpA mutant had
decreased bacterial numbers in the liver (Figure 2A), but not
in kidneys (Li et al., 2010). This raised the question as to
why the effect of ccpA inactivation was specific to the liver.
Notably, glucose concentrations in the liver are elevated in
comparison to those found in blood and intestinal fluids of
the same animals (Appelboom et al., 1959; Wals and Katz,
1993). These observations suggest that CcpA might contribute
to the infectivity of S. aureus in hyperglycemic individuals.
To address this hypothesis, the infectivity of strains Newman,
MST14, and MST14 pCN34_ccpA was assessed in an acute
pneumonia model using female NOD mice that spontaneously
develop a type 1 diabetes between 15 and 30 weeks of age
(Leiter, 2001). Consistent with the pneumonia model using
C57BL/6N mice (Figure 1A), challenging normoglycemic NOD
mice (blood glucose level ≤10 mM) with any of the three strains
resulted in equivalent CFU counts in lung tissue homogenates
(Figure 3A) and BAL (Figure 3B) 24 h post-infection. Similarly,
the total eukaryotic immune cell counts in BAL were comparable
between all groups (Figure 3C), indicating an analogical course
of infection caused by the three S. aureus strains. In contrast,
infection of age-matched diabetic NOD mice (blood glucose level
≥20 mM) with the 1ccpA mutant MST14 significantly increased
the bacterial loads relative to the wild-type strain in lung tissue
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enhanced bacterial loads in the tissue surrounding the catheter
(∼1-log; Figure 5B) compared to mice infected with the 1ccpA
mutant strain MST14. In total, these data suggest that CcpA
is critically important for the pathogenesis of S. aureus in
hyperglycemic individuals.

CcpA Promotes Hemolysis in a
Glucose-Rich Environment
CcpA increases the transcription of the α-hemolysin encoding
gene hla in a glucose-responsive manner (Seidl et al., 2006; Leiba
et al., 2012), and this toxin is a major virulence factor of S. aureus
(reviewed in Vandenesch et al., 2012). To determine whether
CcpA-mediated changes in hla transcription translate into a
greater α-hemolysin accumulation, the capacities of S. aureus
strain Newman and its ccpA derivatives to lyse rabbit erythrocytes
were determined. Rabbit erythrocytes are particularly sensitive
to the pore-forming toxin α-hemolysin (Cooper et al., 1966).
When S. aureus strains Newman, MST14, and MST14 harboring
pCN34_ccpA were streaked onto RBA plates lacking glucose, all
three strains produced small and comparable hemolytic zones
surrounding the growing colonies (Figure 6A). In contrast, when
the three strains were streaked onto RBA plates supplemented
with 0.5% glucose (∼28 mM), strains Newman and MST14
harboring pCN34_ccpA produced larger hemolytic areas than
strain MST14 (Figure 6B), suggesting that CcpA augments αhemolysin accumulation in a glucose-rich environment.

DISCUSSION
Pathogenic bacteria commonly link virulence determinant
synthesis with central metabolic pathways (Eisenreich et al.,
2010; Rohmer et al., 2011; Richardson et al., 2015). In S. aureus,
this linkage is mediated via a number of catabolite-responsive
regulatory proteins, such as CcpA (Seidl et al., 2006), CcpE
(Hartmann et al., 2014), CodY (Montgomery et al., 2012), and
the RpiR homologs RpiRb and RpiRc (Zhu et al., 2011). For
most of these regulators (i.e., CcpE, CodY, and RpiRc), an
attenuating effect on infectivity of S. aureus is observed in murine
infection models (Montgomery et al., 2012; Ding et al., 2014;
Hartmann et al., 2014; Balasubramanian et al., 2016; Gaupp
et al., 2016). Interestingly, only the glucose-responsive regulator
CcpA positively contributes to the infectivity of S. aureus in mice
(Li et al., 2010). In vitro findings demonstrate that 4 mM of
glucose is sufficient to fully activate CcpA (Seidl et al., 2008a),
suggesting it is active in normoglycemic mice with fasting blood
glucose levels of 7–9 mM (Berglund et al., 2008). However, the
in vivo observation of Li et al. (2010), indicating a negative
effect of ccpA inactivation on bacterial loads in liver but not
kidneys, suggest that CcpA might require elevated glucose levels
to modulate the infectivity of S. aureus. This suggestion is
consistent with our observations regarding the contribution of
CcpA to infectivity of S. aureus under normo- and hyperglycemic
conditions; specifically, CcpA’s influence is only realized under
elevated glucose conditions.
While the influence of S. aureus CcpA on infectivity is
predominantly seen in diabetic mice, the effects of CcpA on

FIGURE 3 | Effect of a ccpA deletion on infectivity of S. aureus in NOD
mice in an acute pneumonia model. Age-matched diabetic and
non-diabetic NOD mice were infected intranasally with 5 × 107 CFUs of
S. aureus strain Newman (black symbols), its 1ccpA derivative MST14 (white
symbols), and MST14 trans-complemented with plasmid pCN35_ccpA (gray
symbols), respectively (n = 5–6 per group). Mice were euthanized 24 h p.i.,
and bacterial loads in homogenized lung tissue (A) and BALs (B) determined.
In addition, the total eukaryotic immune cells in BALs were investigated (C).
Each symbol represents an individual animal, and horizontal bars indicate the
median of all observations. *P < 0.05; **P < 0.01 (Mann–Whitney U-test).
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FIGURE 4 | Effect of a ccpA deletion on infectivity of S. aureus in NOD mice in a footpad swelling model. Cells of S. aureus strain Newman (black symbols)
and its 1ccpA derivative MST14 (white symbols) were injected subcutaneously into the footpads of age-matched diabetic and non-diabetic NOD mice (n = 8 per
group), respectively, and swelling of the footpads were measured on a daily basis in reference to the uninfected footpads. (A) Time course of footpad swelling of
S. aureus-infected mice. Data shown represent the means ± SEM. (B) Bacterial loads of S. aureus strain Newman (black symbols) and MST14 (white symbols) in
infected feet 11 days p.i. Each symbol represents an individual animal, and horizontal bars indicate the median of all observations. *P < 0.05; **P < 0.01
(Mann–Whitney U-test).

FIGURE 5 | Effect of CcpA on infectivity of S. aureus in NOD mice in a catheter-related infection model. Sterile catheter segments were inserted
subcutaneously into diabetic and non-diabetic NOD mice (n = 6 per group) and subsequently infected with cells of S. aureus strain Newman (black symbols) and
MST14 (white symbols). On day 11 after infection, edema end points at the insertion site were determined, and the catheters and the surrounding tissues removed
and separated. Bacteria adherent to the catheters were detached by vortexing in saline, and tissue samples were homogenized in saline. Edema end points at day 11
p.i. (A), and bacterial loads in tissues surrounding the catheters (B) and in catheter lumen 11 days p.i. (C) are depicted. Each symbol represents an individual animal,
and horizontal bars indicate the median of all observations. *P < 0.05 (Mann–Whitney U-test).

and increasing the level of the pro-inflammatory cytokine
IL-1β in infected tissue, which induces a neutrophil influx
to the site of infection (reviewed in Berube and Bubeck
Wardenburg, 2013). Together, reduced α-hemolysin production
by the 1ccpA mutant, strain MST14, likely contributes to
the attenuation of infection symptoms in the footpad swelling
model and the catheter related infection model in hyperglycemic
NOD mice (Figures 4, 5). Decreased α-hemolysin synthesis
would also contribute to decreased CFU and Il-1β and KC
concentrations observed in livers of strain MST14 infected
C57BL/6 mice (Figure 2). This would also explain the augmented
Il-1β concentrations found in liver homogenates of mice
infected with MST14 pCN34 ccpA_Ala (Figure 2B). Namely,
complementation of strain MST14 with the mutated ccpA_Ala
plasmid prevents the Stk1 facilitated phosphorylation of CcpA,
which blocks CcpA binding to the hla promoter (Leiba
et al., 2012), thereby increasing α-hemolysin synthesis and

pathogenesis differ between disease niches. Specifically, CcpA
functions as an attenuator of S. aureus virulence in the
pneumonia model (Figure 3), while in the footpad swelling
model (Figure 4) and the catheter related infection model
(Figure 5) inactivation of ccpA significantly decreased infection
symptoms. While the mechanism(s) by which CcpA mediates
differential virulence responses in different niches remains
speculative, in vitro data provide clues to the nature of this
mechanism(s).
CcpA enhances the hemolytic potential of S. aureus
in a glucose-rich environment (Figure 6), and promotes
transcription of the α-hemolysin gene hla during postexponential growth in vitro (Seidl et al., 2006; Leiba et al.,
2012). This secreted pore-forming exotoxin is crucial in S. aureus
skin and soft tissue infections (SSTI; reviewed in Kobayashi
et al., 2015). In particular, α-hemolysin destabilizes the dermis
by inducing tissue barrier disruption and host cell cytolysis,
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FIGURE 6 | Effect of CcpA on the hemolytic activity of S. aureus. Single colonies of S. aureus strains Newman (WT), MST14 (Newman 1ccpA), and MST14
complemented with plasmid pCN34_ccpA, respectively, were streaked onto rabbit blood agar plates in the absence (A) or presence of 0.5% glucose (B), and grown
for 24 h at 37◦ C. The photographs are representative of three independent experiments. The image depicted in A was recorded in back-light mode to visualize the
hemolytic areas.

(Recklinghausen, Germany), and cantonal veterinary office of
Basel-Stadt (Switzerland), respectively.

subsequently the levels of IL-1β in liver (Figure 2B). Taken
together, it is likely that the main effect of CcpA in these animal
models is exerted through changes in α-hemolysin synthesis.
In S. aureus, α-hemolysin and protein A (SpA) are inversely
regulated (Goerke et al., 2000; Oogai et al., 2011; Gao et al.,
2016). In other words, when α-hemolysin synthesis is elevated,
SpA synthesis is decreased. This is significant because SpA
is important for the infectivity of S. aureus in lung infection
models (Gomez et al., 2004; Bubeck Wardenburg et al., 2007).
SpA activates and controls the pro-inflammatory response by
interacting with the TNF receptor 1 and the epidermal growth
factor receptor on airway epithelial cells, which contributes to the
pathogenesis of staphylococcal pneumonia (reviewed in Parker
and Prince, 2012). Importantly, spa transcription is strongly
repressed by CcpA in response to glucose availability (Seidl et al.,
2006). Based on these observations, the increased bacterial loads
in the lungs and BALs of diabetic mice challenged with MST14
are likely due to enhanced synthesis of SpA by the 1ccpA mutant
(Figure 3). More importantly, these data suggest the inverse
relationship between α-hemolysin and SpA contributes to disease
severity within different niches.
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